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Introduction: 
Although a modern scientific accomplishment, the transplantation 
of organs from an organism to one genetically different is an ancient 
concept. The Egyptian Sphynx is a heterograft (to use the modern 
terminology) between the body of a lion and the head of a human. 
The idea of genetically different tissues living together in 
the same organism also pervaded Greek mythology. The Centaur was 
a heterograft between a horse and a man; the Minotaur had the body 
of a bull and the head and torso of a human; and the Chimera had the 
head of a lion, the body of a goat, and the tail of a serpent. 
Modern studies on tissue transplantation began with Carrel early 
in this century, but it was not until 1953 that Billingham, Brent, and 
Medawar^ reported the artificial induction of tolerance to tissue - 
in this case, skin - from one animal to a genetically different member 
of the same species. These investigators, using Burnet and Fenner’s 
"self-marker" concept as a theoretical model, sttempted to destroy 
immunologically competent cells that could react against the tissue of 
strain A mice in CBA mice by injecting cells and tissue debris from 
testis, kidney, and spleen from A mice into fetal CBA mice. The CBA 
mice were challenged with skin from A mice at eight weeks of age. 
Whereas no skin grafts from A mice were accepted by control CBA mice 
that had received no injections, 60$> of the treated CBA mice accepted 
skin grafts from A mice. 
This experiment was the first successful attempt to overcome the 
immunological response of graft rejection. That homograft rejection is 
an immunological process has been known for many years, Medawar^’J 
thoroughly described the homograft rejection pattern in rabbits. 
Briefly, if a skin graft is transferred from a donor rabbit to an 
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unsensitized recipient, relatively normal healing of donor and recipient 
skin occurs for the first four days. When the skin is grafted, blood 
and lymphatic vessels from the host grow into the donor graft. Blood 
flow from the host to the donor skin is established, and there is 
little cellular infiltration for the first few days. At the end of 
the first week, the exact time depending on the genetic disparity of 
host and donor tissue, thrombosis of the vessels occurs, a leukocytic 
infiltrate appears, and the graft dies and is sloughed within two or 
three weeks. 
At the time of rejection, there is an intense, leukocytic infiltration 
around the blood vessels in the graft and a grossly visible "black band" 
of cells that can be seen at the graft-host junction on the stained 
o 
tissue specimen. The most common infiltrating cell is the lymphocyte, 
but the graft also is invaded by polymorphonuclear leukocytes, immature 
4 
plasma cells, and eosinophils. Primary importance in the rejection 
phenomenon has been assigned to the production of sensitized lymph 
cells in the lymph nodes draining the graft site and the migration 
5,6,7 
of these cells into the graft resulting in its destruction, 
8 9 
Passive transfer experiments ? have shown that regional lymph 
node cells are sensitized to donor antigens. If the cells from a 
sensitized regional lymph node are injected into the skin of the 
animal whose tissue was responsible for the sensitization, marked 
erythema and swelling may be noted at the injection site. The 
importance of lymphatic tissue for graft rejection is shown by 
prolonged survival of grafts in organs with no lymphatic drainage. 
Thus, the anterior chamber of the eye^ the brain,^ and the testis^^?^2 
do not have lymphatic drainage, and homografts placed in these organs 
will survive for prolonged periods. Grafts placed in these organs fail 
to provoke an immune response. These grafts will be rejected, however, 
if the host is immunized against donor tissue before 0 or after grafting. 
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Although most investigators agree that invasion of donor skin 
by host lymphocytes is essential for homograft rejection, the role 
13 
of circulating antibodies is still debated. Medawar believes 
classical circulating antibodies play no essential part. These 
14 16 
antibodies may be demonstrated by a number of methods, ’ ’ 
but their role in graft rejection is undetermined. Fetal lambs 
can reject skin grafts before they can make gamma globulin;^ 
but skin grafts placed on humans with hypogammaglobulinemia survive 
for prolonged periods. 'L(J Homologous and heterologous cells placed 
in Millipore diffusion chambers and then inserted into the peritoneal 
cavity of presensitized mice were destroyed if the pores in the filter 
were large enough for host cells to enter but were not destroyed if 
only serum entered. '’ Another source of evidence that humoral 
antibodies play little role in graft rejection is the consistent 
failure to demonstrate passive transfer of homograft sensitivity by serum 
5 21 22 
alone. ’ However, Haskova has reported the destruction of previously 
accepted skin grafts in ducks by injecting serum from other ducks 
immunized against donor tissue. 
The immunological nature of homograft rejection also is shown by 
the earlier and more violent rejection of a skin homograft placed on 
2 4 
a previously sensitized host. ? The "second set reaction" is 
characterized by earlier rejection beginning within the first -week 
of grafting. In this type of rejection, graft tissue is not invaded 
by host blood vessels, and the graft never becomes vascularized. No 
time is needed for sensitization of the host, and the graft is quickly 
and violently rejected, Failure of vascularization causes the graft to 
turn white for lack of blood - hence, the alternate name - "white graft 
reaction." 
The preceding paragraphs attempt to show that the phenomenon of 
. 
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graft rejection involves an immunological process. Investigators 
trying to induce tolerance to foreign grafts have sought methods of 
surpressing the immune response long enough for the donor tissue to 
become part of the host or to abolish completely the host's reaction 
against the donor. 
The first successful induction of tolerance in 1953 by Billingham, 
Brent, and Medawar^ was, in part, a test of the immunological theory 
23 24 
of Burnet and Fenner. ’ In turn, Burnet and Fenner based their 
"self marker concept" partly on the work of Owen.^’^ In 1945, Owen 
discovered that dizygotic twin cattle had, in addition to their own 
red blood cells, the same type of erythrocytes as their twin. After 
27 
Lillie found that dizygotic cattle often share a common blood supply 
in utero, Owen proposed that erythrocytes and erythropoeitic cells 
were freely exchanged during the embryonic period and were able to 
survive in the mature animal. This red cell chimerism has also been 
28 29 30 31 
demonstrated in sheep, chickens, ^ and man. 5 
Burnet and Fenner's theory of immunologic specificity proposed 
that during the embryonic life the organism lears to recognize its own 
antigens as "self" so that it is unable to react against them later. 
On the other hand, if the animal is exposed to antigens after birth, it 
recognizes them as "not self" and produces antibodies against them. 
On the basis of this theory and Owen's discovery of red cell chimerism 
is cattle, Burnet and Fenner predicted that foreign material introduced 
into the embryo would be recognized as "self", and the animal would be 
32 
unable to react immunologically against them later. Burnet et al. 
failed to provide experimental evidence for this prediction, using 
antibody production in the chicken as the experimental model. 
Other investigators, however, were able to provide evidence for 
Burnet and Fenner's theory. In 1950, Gross^S discovered that lymphatic 

leukemia would, cause leukemia in another inbred mouse strain if the cells 
were transplanted to newborn mice but not if they were transplanted to 
q4 
older mice of that strain. But Kaliss and Snell made successful 
homotransplantations of mouse tumors after giving injections of lyophilized 
kidney, liver, and spleen from the donor strain. 
35 36 
Anderson et al., j.n 1951? and Billingham et al. , one year later, 
added to Owen’s findings and supplied evidence for Burnet and Fenner's 
prediction, when the skin grafts they exchanged between dizygotic twin 
cattle survived permanently. 
It was not until 1953 that Billingham, Brent, and Medawar"*" first 
artificially produced immunological tolerance to skin homografts in 
mice. The authors also describe the induction of acquired tolerance to 
skin grafts in chickens by injecting donor blood into the chick embryo. 
Skin transplanted to the prepared host after hatching survived permanently. 
Although this paper deals with skin transplantation in mice, many 
other species are being used to study transplantation phenomena: hagfish, 
paddlefish, ^ lamprey, ^ chickens,"*"’ ^ ducks,22 hamsters, rats,^’^ 
guinea pigs,*42 cattle,35?36,44,46,50 rabbits,turkeys,3^?39 anq pheasants. 
Tissues other than skin have been used to investigate transplantation: 
tumor,3^?^5 kidney,*4^ liver,^ endocrine gland,'^,*4" spleen,^ lung,^ 
and heart.51 
52 
Billingham et al. believed donor cells had to be injected before 
birth to establish tolerance to future skin grafts. Optimal time for 
injecting foreign cells depended on the species, since some aminals 
develop immunological competence during the embryonic period. The few 
days before and after birth in the mouse were a "null period" during which 
foreign cells elicited neither tolerance nor immunity. For each species 




However, In 1955? Woodruff and Simpson and Egdahl et al, J 
reported that tolerance to skin homografts could be induced in the rat 
by injecting spleen cells as late as two weeks after birth. Other workers 
also demonstrated that immunological tolerance could be produced after 
birth. As far back as 1951 Kaliss and Snell-1 reported growth of 
transplanted mouse tumor following injection of lyophilized donor spleen, 
kidney, and liver after birth. Others showed tolerance also could be 
produced in chickens after hatching. 
54 
Similarly, Aust et al. produced tolerance to an adenocarcinoma 
in A strain mice by injecting tumor cells of the C3H strain a few hours 
after the host was born. However, tolerance could not be produced if 
the tumor cells were transplanted in the adult animal. 
38 55 56 57 
In 1957? Billingham and Brent ’ 5 and Billingham and Martinez 
58 
et al, provided evidence that acquired immunological tolerance could 
ie produced in the newborn mouse by intravenous or intraperitoneal injection 
of spleen cells from the donor mouse strain. Tolerance could not be 
produced if the cells were in ected into the subcutaneous tissues of the host. 
46 
Gombos has reported successful homotransplantation of kidneys in 
young dogs by completely replacing their blood with blood from the 
44 
future donor. However, Fowler showed no prolongation of survival of 
skin homografts in puppies following blood and leukocyte transfusions. 
When, in 1959? Shapiro et al.5L) and Mariani et al,'^ showed 
immunological tolerance could be produced in adult animals as well, 
Burnet and Fenner’s explanation of immunological tolerance had to be 
60 revised. Thus Mariani et al, were able to induce tolerance to skin 
isografts across the male-female histocompatability barrier in C57B1/1 
and A strain mice by injecting the adult female mice (who normally reject 
' 
skin from male mice of the same strain because of a sex-linked histo- 
compatability barrier) with twenty million spleen cells or by making 
the male and female mice parabiotic partners. These experiments and 
61-69 
others showing tolerance could be produced in adult mice called 
for revising Burnet and Fenner’s "self marker concept". 
The similarity of immunological tolerance and the inhibition of the 
immune system by antigen overloading (immunological paralysis) has been 
pointed out by Good et al.u 5 ’ ’ Immunologichi paralysis is the 
inhibition of immunization and sensitization to antigens caused by 
injecting large quantities of antigen. Through such intramuscular 
injections, Sulzberger;3?'^ demonstrated the prevention of sensitization 
to neoarsphenamine in guinea pigs. Immunological paralysis to pneumococcal 
75 7 6 
polysaccharide was demonstrated by Felton and Ottinger and by Felton,' 
They showed that whereas 0.0005 mg. of pneumococcal polysaccharide would 
immunize the mouse against the pheumococcus, 0.5 mg. of pneumococcal 
polysaccharide would not protect the mouse from the pneumococcus. 
Immunological tolerance or "immunological unresponsiveness" to 
protein antigens by the injection of large doses of the antigen has been 
77-80 
demonstrated in rabbits by a number of investigators. This 
unresponsiveness was specific for the protein administered, the antibody 
production to other proteins being unaffected. 
81 
Tolerance to cellular antigens was demonstrated by Mitchison. 
He was able to maintain homologous erythrocytes labeled with Cr^l in the 
circulation of chickens by repeated administration of red blood cells. 
The transferred red cells were eliminated by a nonimmune mechanism. 
In all these experiments, the necessity of the persistence of 
antigen for the maintainance of immunological unresponsiveness is evident. 
Other mechanisms of immunological tolerance have been reviewed by 
■ . • 82 
Hasek et al. These investigators have proposed that antigen 
. 
■8- 
responsible for the induction of tolerance could activate an adaptive 
enzyme so that the antigen would be broken down by a mechanism other 
than that which leads to immunity. Another mechanism is that the tissue 
antigen has an instructive function causing some change in the genetic 
structure of the mesenchymal cells or transfer of its own genetic material 
to the host that would inhibit the formation of antibodies against 
grafted material. Experimental evidence is lacking for these theories. 
Most investigators believe antigen must be present for the maintainance 
of tolerance.73*31,82 q00(^ et ^-^70-72,83 pave drawn a direct parallel 
between immunological tolerance and immunological unresponsiveness. Both 
these phenomena are similar in specificity, necessary persistence of 
antigen, greater ease of induction in very young animals, and possibility 
of producing unresponsiveness in adult animals with large quantities of 
antigen. 
The argument has been that lymphoid cells given to the fetus or 
neonate have survived and multiplied in the host while constantly putting 
out tissue antigen. This constant supply of antigen to the host has 
created a state similar to immunological paralysis produced by Felton 
with pneumococcal polysaccharide. When skin subsequently was grafted, 
the host was unable to react against the graft because the antigens 
in the graft that normally immunize the host were the same as those 
produced by the lymphoid cells with which it was previously injected 
84 
and to whose antigens it is now unable to respond. It has been demonstrated 
that mice made tolerant are chimeras in their lymphoid cell populations; 
they have both host and donor cells. Since these cells are living in 
the host, they always are producing isoantigens, thus keeping the host 
animal loaded with donor antigen and consequently unresponsive and 
tolerant. The skin homograft continues to produce antigen as well and 
adds to the tolerance-producing antigen production of the previously 

-9- 
injected donor cells. 
This explanation predicts that immunological tolerance is a 
dose-response relationship. Small doses of antigen produce immunity; 
large doses of the same antigen cause immunological unresponsiveness or 
tolerance. Thus, even very young animal might be immunized if given 
small enough doses of antigen. Howard et have shown that small 
quantities of homologous spleen cells given to newborn mice could produce 
immunity. Fetal lambs, ' guinea pigs, ’ and human neonates' also are 
capable of immunological responses. 
The theory paralleling immunological tolerance to immunological 
paralysis also suggests tolerance can be produced in any animal of any 
age with enough antigen. Antigen must be given in large doses repeatedly, 
since it is constantly being metabolized by the host. In 1961, Shapiro 
64 
et al. induced tolerance to (A x C3H) F^ hybrid skin grafts in adult 
C3H mice by administering 1,500 million donor cells to the host C3H mice 
in seven to eleven weeks. 
Tolerance also has been induced in mice with cell-free extracts of 
lymphoid cells. In i960, Billingham and Silvers^ were able to induce 
tolerance to skin of C57 male mice in C57 female mice by the previous 
90 
administration of a cell-free extract of male lymphoid cells. Linder 
induced tolerance across the male-female histocompatability barrier in 
adult mice with homogenates of kideny, spleen, and liver. Martinez et al.^’^l 
92 
and Kelly and Brown also Induced tolerance across the male-female barrier 
in C57B1/.1 mice, using cell-free preparations of liver, kidney, heart, 
and blood. And Martinez et al./<J produced tolerance to homologous skin 
grafts in mice across stronger histocompatability barriers including the 
strong H-2 locus with disrupted spleen cells. 
The following experiments are an extension of the work previously 
mentioned which show the capability of disrupted cells and subcellular 
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fractions to induce immunological tolerance. They are an attempt 
to define further the cell constituents responsible for tolerance, 
71 




Animals: Mice of the C57B1/1, A, C3H, and BALB/C strains were used in 
Q7 
these experiments. Eichwald and Silmser' first reported the inability 
of C57B1/1 female mice to accept skin isografts from C57B1/.1 male mice, 
but female skin grafts were uniformly accepted by male mice. This find¬ 
ing is thought98>99 to be due to the presence of a histocompatability 
gene on the Y chromosome. Since this combination is a weak histo¬ 
compatability barrier, it provides a sensitive method for testing the 
induction of immunological tolerance. The mice were obtained originally 
from the colony of Dr. J. J. Bittner and have been inbred for over 100 
generations. 
In these experiments, female C57B1/1 mice were from 45 to 75 days 
old when the experiment was begun. Spleens, livers, and skin grafts 
were taken from male mice ranging in age from 45 to l80 days old. 
In other parts of these experiments, mice of the A, C3H, and BALB/C 
strains were used. These mice also were obtained from the colony of 
Dr. Bittner and have been inbred for over 100 generations. The BALB/C 
mice were 90 to 180 days old when skin grafts were removed. 
Newborn C3H mice received injections of spleen fractions and were 
35 days old at the time of grafting. The A strain mice ranged from 60 
to 360 days old. 
The C57B1/1 and BALB/C mice differ at the H-2 histocompatability 
barrier; the A and C3H mice also differ at this barrier, 
Preparation of Antigenic Material: Male C57B1/1 mice were sacrificed 
with ether anesthesia, their skins were cleaned with 70% alcohol, and 
their spleens were immediately excised and placed in ice-cold .lactate- 
Ringer’s saline solution (Cutter). The spleens were reduced to a paste 
in a tightly fitted, ground glass homogenizer with an internal diameter 
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of one-half inch containing two to four milliliters of lactate-Ringer's 
saline solution. Cells were disrupted by subjecting the paste to four 
cycles of freezing and thawing. Solid carbondioxide (-60° C.) was used 
for freezing, and warm tap water was used for thawing. Microscopic 
examination confirmed that no intact cells remained after the last cycle 
of freezing and thawing. The spleen capsules were removed by filtering 
the homogenate through surgical gauze. 
The spleen cell homogenate was separated into subcellular fractions 
by centrifugation. The particulate fraction was the precipitate removed 
by centrifugation of the spleen cell homogenate at 15,000 g for 10 minutes 
in a Spinco Model L ultracentrifuge with a number 40 rotor. This 
precipitate contained cell walls, nuclei, mitochondria, and other large 
cell debris. 
The supernate then was centrifuged at 105,000 g for 60 minutes. The 
sediment from this centrifugation, containing the cell microsomes was 
termed the microsomal fraction. The soluble fraction was the remaining 
supernate. Each fraction was washed and suspended in lactate-Ringer7s 
solution. The concentration was two spleen equivalents per milliliter. 
(A spleen equivalent is that amount of material removed from one spleen.) 
These fractions were prepared from the spleens of A strain mice in an 
identical manner. 
In addition, a nTris"-extracted particulate fraction and a 
RNAse-treated microsomal fraction were prepared from the spleens of 
C57Bl/l male mice. 
The ’’Tris"-extracted particulate fraction was prepared by extracting 
the particulate fraction with 0.1 M trihydroxy-methyl-amino-ethane 
("Tris") pH 8.7 for 30 minutes at 25° C. After centrifugation at 
15,000 g for 20 minutes, the precipitate was suspended in lactate-Ringer's 
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saline solution with a final concentration of two spleen equivalents 
Per milliliter. 
Preparation of the KNAse-treated microsomal fraction included the 
suspension of the microsomal fraction in normal saline with a concentration 
of four spleen equivalents per milliliter and incubation with 0.05 nig. 
bovine pancreatic KNAse (Sigma Chemical Company) in 0.01M "Tris" 
acetate buffer, pH 7.5; per milliliter microsome suspension. This 
mixture was dialysed at 4° C. against 0.01 M "Tris” buffer for 24 hours. 
After this period, a test for RNA was made by the orcinol method on an 
aliquot of the sample. This test was uniformly negative. 
In a subsequent experiment, the microsomal fraction was divided 
into a ribosomal fraction and a microsomal membrane fraction. Ribosomes 
were separated from the microsomes of the spleens of C57B1/1 male mice 
according to Korner's method.The spleen cells were disrupted in a 
ground glass homogenizer. After the large cell particles were removed 
by centrifugation at 15,000 g for 10 minutes, the supernate was collected 
and one-ninth its volume of five per cent sodium deoxycholate in 0.03 M 
"Tris" buffer, pH 8.2 was added. The ribosomes could be isolated from 
the membranes by centrifugation at 105,000^g for two hours. To the 
ribosomes isolated from 25 spleens (approximately 1.75 gm. wet weight) 
was added 0.02 mg, bovine pancreatic RNAse (Sigma Chemical Company) 
in 0.001 M "Tris" acetate buffer and 0.005 M ethylene-diamine- 
tetraacetic acid (EDTA), pH 7*5* This mixture was incubated at room 
temperature (25° C.) for one hour and then kept at 4° C. for 17 hours. 
These two fractions were then suspended in normal slaine, one-half 
spleen equivalen per milliliter, for injection. 
In another experiment, liver tissue of C57B1/1 male mice was 
used to prepare a microsomal fraction and a particulate fraction. 
Livers of C57B1/1 male mice were excised and frozen at -20° C. until 
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used, (one day to two weeks) , A total of 231 gm. of liver (wet weight) 
was used in this experiment. The frozen liver tissue was thawed and 
homogenized in a Waring blender and a ground glass homogenizer. Large 
pieces of particulate matter were removed by centrifugation at 15,000 g 
for 10 minutes in a Spinco Model L-2 ultracentrifuge in a number 30 
rotor. The supernate was then centrifuged at 105,000 g for two hours. 
The pellet from this centrifugation was dispersed in five per cent 
sodium deoxycholate in isotonic sodium chloride solution. The mixture 
was then centrifuged for two hours at 105,000 g in a Spinco zonal 
ultracentrifuge using a 30°]o to 50'/> sucrose gradient The contents of 
the rotor were withdrawn in forty 40 ml. aliquots as the rotor was 
spinning at 4,000 g. Relative protein concentraction of each aliquot 
was estimated by recording the optical density of the sample at a 
wavelength of 280 mu on a Beckman Model D spectrophotometer. Five peaks 
were found and were determined to correspond to Svedberg units of 10S, 
30S, 50S, and 120S. The fifth peak represented the material at the 
bottom of the rotor. The aliquots corresponding to the 120S peak 
(determined to be the liver microsomes) were dialysed against 0.001 M 
"Tris" buffer, pH 7.4, for four days at 4° C., at the end of which 
the white precipitate was collected by centrifugation at 105,000 g for 
60 minutes. 
The aliquots representing the fifth peak, the particulate matter, 
were centrifuged at 105,000 g for two hours. The pellets from these 
two fractions were divided into 13 portions and stored at -20® C. until-... 
used. 
Injections: Fractions prepared from C57Bl/l male spleens were injected 
into C573l/l female mice twice weekly. The first injection was given 
intravenously through a tail vein. Fifty USP units of heparin (Liquaemin 
Sodium, Organon, Inc.) was given before the intravenous injections. 

Each injection included one spleen equivalent of that fraction. Subsequent 
injections were performed intraperitoneally. Some mice died after the 
intravenous injection due to embolization of the' injected material. These 
animals were excluded from the results. Skin grafting was performed 
after the fourth injection, and semiweekly injections were continued for 
an additional four weeks. 
The particulate and microsomal fractions obtained from C57Bl/l 
male livers were injected into female mice in 13 equal parts. Intra¬ 
venous administration was alternated with intraperitoneal injection. 
No heparin was given before the intravenous injections. The C57B1/1 
female mice were given seven injections in a period of ten days and 
then were grafted with skin from C57B1/1 male mice. Six injections 
were given in the ten days after grafting. 
The injection schedule of spleen fractions from A strain mice into 
newborn C3H mice was 0.2 spleen equivalent three times per week for the 
first week, 0.5 spleen equivalent three times per week for the next two 
weeks, and one spleen equivalent three times per week for the next two 
weeks. Tumor grafts were placed subcutaneously into the C3H mice at the 
end of the fifth week. Control mice that received no injections also 
were grafted at five weeks of age. One spleen equivalen was injected 
twice weekly thereafter into the experimental animals -until graft 
acceptance or rejection was determined (approximately four weeks). All 
injections were given intraperitoneally. 
Control C57Bl/l female mice were injected with "Tris" buffer 
solution or the RNAse solution and followed the same injection as the 
experimental mice. Other control mice received no injections. 
Skin Grafts: Skin grafts from C57B1/1 male to C57B1/1 female mice 
58 
were administered by the standard method of this laboratory. After 
the mice were anesthetized with sodium nembutal, the hair was clipped 
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from the ventral aspect of the male donors and the dorsum of the 
female recipients. The skin was washed with 70% alcohol, and a two 
centimeter square piece of skin was removed from the ventral surface 
of the male donor, rotated l80 , and placed on a graft hed of the same 
size on the hack of the female host. The graft hed had heen prepared 
previously hy removing a similar sized piece of skin from the female. 
The skin grafts were secured in place with interrupted 5-0 silk sutures 
or with metal skin clips. Reversing the grafts facilitated the 
evaluation of subsequent graft acceptance or rejection, since the hair 
of the graft grows in a direction opposite to the host’s. 
The grafts were evaluated hy grosls inspection. The criteria for 
graft acceptance (and thus for immunological tolerance) were lack 
of inflammatory or indurative signs (I. e. rejection) and growth of 
new hair 60 days after grafting. Skin grafts were observed for nine 
month s, 
To determine whether tolerance produced hy the spleen or .liver 
fractions was specific for that tissue genotype or was merely a 
nonspecific inhibition of the immune response, some of the animals 
tolerant to C57Bl/l male skin grafts were grafted with skin from 
BALB/C mice. The tolerant C57B1/1 mice were grafted after the male 
skin had heen in place six months, 
Tumor Graftss A mammary adenocarcinoma from A strain mice was grafted 
to C3H mice. A small peice of tumor, approximately two millimeters 
on a side, was placed subcutaneously into the left groin of C3H mice 
through a small incision in the left flank. Ether anesthesia was used, 
and the incision was closed with a singly 5-0 silk suture or skin clip. 
The criterion for acceptance of the tumor was growth of a mass at the 
site of implantation with the eventual death of the host. These masses 
grew to he several centimeters long hy the time the mouse died. In 







The results of the skin grafts placed on C57B1/1 female mice receiving 
subcellular fractions from male C57B1/.1 mice are shown in Table I. The 
microsomal fraction and particulate fraction possess the ability to 
induce immunological tolerance to male skin isografts in female mice. 
Five of seven (71$) female mice injected with the particulate fraction 
accepted male skin grafts, and six of eight (75$) female mice receiving 
the microsomal fraction accepted male skin grafts. Only two of eight 
(25$) female mice that were given the soluble fraction accepted syngeneic 
male skin grafts. Of the uninjected control mice, only two of fifty-nine 
(3$) accepted male skin grafts. 
Figure I shows the female control mice which had been grafted with 
male skin. The grafts were applied 70 days before the photograph was 
taken. Only shrunken scar tissue remains where the graft was. Figure 
II shows 70 day-old male skin grafts on the dorsum of female mice 
injected with the microsomal fraction. The grafts did not shrink and 
show a luxuriant growth of hair. All the host’s hair remained black, 
but some of the donor hair lost its pigmentation following grafting. 
Graft hair was coarser and lacked the sheen of the host hair. 
Table I also indicates that destruction of the microsomal RTTA 
by bovine pancreatic KNA.se did not appreciably alter the ability of 
this fraction to induce tolerance. Six of eleven (55$) female mice had 
intact male skin grafts at the end of two months. The grafts were still 
viable when the animals were sacrificed nine months after grafting. Three 
of the mice can be seen in Figure III, which shows the coarse, white 
hair of the grafts. The hair of the host mice was not completely 




Extraction of the particulate fraction with "Tris" buffer did not 
weaken the ability of this fraction to produce tolerance. Nine of 
eleven (8l$) mice retained their skin grafts for at least nine months. 
The control mice injected with either "Tris” buffer or the RNAse solution 
showed no graft acceptances, none of twelve and none of ten, respectively. 
Also included in Table I are the survival data of male skin grafts 
on C57B1/1 female mice that received the ribosomal fraction and the 
microsomal membrane fraction. Of twenty female mice injected with 
ribosomes prepared from the spleens of C57B1/1 male mice, four (20$) 
retained skin grafts with good hair growth longer than two months. 
Two of eight (25$) injected with the microsomal membrane fraction had 
intact skin grafts at the end of two months. The grafts in both groups 
remained in place with no sign of rejection for an additional six months. 
Table II shows the results of grafts acceptance in the C57B1/1 
female mice injected with subcellular fractions prepared from the livers 
of C57B1/1 male mice. Nineteen of twenty-two (86$) female mice 
injected with liver particulate fraction had healthy, intact grafts at 
the end of eight months. Sixteen female mice were injected with 
the liver microsomal fraction, and twelve (75$) of them retained the 
male skin grafts for at least eight months. 
Thirty-four C57B1/1 female mice tolerant to male skin grafts 
were grafted with BALB/C skin when the C57B1/1 male skin grafts had 
been in place for six months. None of these grafts survived more than 
one week, the same as control mice. Their rejection did not affect the 
survival of the intact male skin grafts. These data can be seen in Table III. 
Table IV shows the results of the attempt to induce tolerance 
across the H-2 histocompatability barrier in C3H mice to mammary 
adenocarcinoma of Astrain mice. Six of seven (86$) C3H mice 
. 
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in jected with the microsomal fraction accepted A tumor grafts; the 
tumors eventually caused their death. Similarly, five of eight (63#) 
C3H mice treated with the sedimented particulate fraction and two 
of seven (28$) C3H mice receiving the soluble fraction accepted 
tumor grafts from A strain mice. None of the ten control mice that 




It has "been little more than a decade since Billingham, Brent, 
and Medawar first artificially induced immunological tolerance in 
fetal mice by injecting them with viable donor spleen cells. Since that 
time practical accomplishment of transplantation and theoretical 
speculation have made much progress. From discoveries made in the 
mouse and dog, man has come to Benefit from progress in kidney 
transplantation. Lung, liver, and heart transplantation also have 
been performed in humans. 
Ihe present experiments and others have necessitated a reconsideration 
of the theories of immunological tolerance. Using Burnet and Fenner’s23’24 
"self marker concept” and clonal selection theory, early investigators 
explained that induction of tolerance in mice had to be effected 
during the intrauterine period or within one or two days of birth. 
The clone of cells directed against the injected donor cell antigens 
could be fooled into believing these*.antigens were actually part of itself 
(the host); the clone of cells that would be directed against the donor 
cell antigens if injected at a later date, would conveniently die or 
be surpressed so that the animal could not react against the antigens 
m a subsequent graft from the original donor animal (or a genetically 
identical one). 
It was not long, however, before this theory had to be revised 
and then discarded entirely. Other workers42*’4^’ 59? 60 that 
immunological tolerance could be accomplished after the immediated 
neonatal pariod and even during adult life when the host was 
immunologically mature, (it also has been demonstrated that fetal and 
newborn animals have the ability to react against antigenic stimulation1?,85-88)# 
It appears that the age at which an animal is made tolerant is not as 
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import ant as the genetic disparity between the donor and the host animal. 
The number of cells or amount of antigenic material needed for tolerance 
seem to be directly proportional to the genetic differences between the 
donor and host. As stated before, the group from Minnesota under 
Good has drawn a direct parallel between the phenomenon of immunological 
tolerance and the inhibition of the immune response by antigen 
overloading. To prevent production of antibodies and, hence, immunity, 
large quantities or repeated injections of polysaccharide or protein 
antigens had to be given. As long as these antigens were present in the 
host, no antibody production could be demonstrated. 
The situation is analogous in producing immunological tolerance. 
A relatively small number of donor cells can produce tolerance in fetal 
or new born animals which have relatively few cells capable of producing 
antibodies (cellular or humoral) to the specific antigens of the 
foreign cells. By surviving and proliferating in the host the donor 
cells continuously produce antigens and keep the host in an unresponsive 
or paralyzed state. The adult, because of higher numbers of antibody- 
producing cells, requires more donor antigen to reach the unresponsive 
state. Therefore, more cells must be administered to an animal that is 
older to render it unresponsive. 
The present as well as previous studies^572,89-92 show- that 
live cells are not necessary for inducing immunological tolerance. 
By repeated administrationg of disrupted cells from the spleen, liver, 
or kidney or of subcellular fractions from spleen or liver cells, it 
is possible to prevent the host from reacting against subsequent skin 
or tumor grafts. The fate of this material, once injected into the host, 
has not been examined, but it may be proposed that examination of the 
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reticuloendothelial cells would provide evidence of antigenic material 
from the donor animal. Grafts remaining on the host animal until its 
death show that tolerance produced by subcellular fractions is permanent. 
The experiments described here offer a suggestion of what part of 
of the cell contains the factor or factors responsible for the induction 
of immunological tolerance. On the basis of these experiments, it appears 
that the crude particulate fraction made up of cell wall, nuclei, 
mitochondria,and other cell debris, and the microsomal fraction both 
contain material capable of inducing a high degree of immunological 
tolerance in C57B1/1 female mice to C57B1/1 male skin isografts. 
Seventy-one per cent (5/7*) of the female mice injected with the 
particulate fraction accepted syngeneic male skin grafts, and 
seventy-five per cent (6/8) of the female mice receiving microsomal 
fraction were made tolerant to skin grafts from male mice. Little 
tolerance-producing ability is present in the soluble fraction; only 
twenty-five per cent (2/8) of the female mice accepted syngeneic male 
skin grafts. 
Extraction of the particulate fraction with "Tris" buffer did not 
diminish its ability to induce immunological tolerance; indeed, 
eighty-one per cent (9/ll) of the female mice injected with this 
fraction and later grafted with male skin grafts kept the grafts intact 
at the end of nine months. Similarly, destruction of the RNA did not 
lower appreciably the ability of the RNAse-treated microsomal fraction 
to effect tolerance to male skin grafts in syngeneic female mice. 
Fifty-five per cent (6/ll) of the C57B1/1 female mice injected with 
* number of grafts accepted/ number of animal grafted 
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the RNAse-treated microsomal fraction were made tolerant to C57B1/.1 
male skin grafts. 
However, when ribosomes were separated from the microsomal membranes 
and these two fractions administered separately to female mice, male 
skin graft acceptance was reduced markedly. Only twenty per cent (4/20) 
of the female mice injected with spleen ribosomes had viable male 
skin grafts at the end of two months. Twenty-five per cent.- (2/8) 
of the female mice receiving microsomal membrane fraction accepted 
male skin grafts. 
Table II shows that liver fractions also can induce a high degree 
of immunological tolerance in C57B1/1 female mice to skin grafts from 
male C57B1/1 mice. Of those mice receiving the particulate fraction 
86 per cent (19/22) of the mice retained male skin isografts longer 
than two months. At the present time, the grafts have been in place 
for eight months and show no sign of rejection. Seventy-five per 
cent (l2/l6) of the female mice receiving liver microsomal fraction 
had intact male skin grafts longer than two months. These grafts 
also show no sign of rejection at the end of eight months. 
It can be argued that the effect of injecting these various spleen 
and liver fractions does not produce specific immunological tolerance. 
Rather, they may act as general inhibitors of the immunological 
response in a manner similar to substances that blokade the reticulo¬ 
endothelial system. If this hypothesis were true, the C57B1/1 female 
mice tolerant of male skin grafts would not be able to reject skin 
grafts from other strains. However, these tolerant C57B1/1 female mice 
did reject skin grafts from BALB/C mice in the normal period of one 
week. This finding provides evidence that the tolerance produced 
by the subcellular fractions is specific. It can be argued, however. 
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that the antigenic challenge presented by the two grafts was not 
comparable, because the male-female histocompatability difference is 
very small, whereas C57B1/1 and BALB/C mice differ at the H-2 locus, 
a formidable histocompatability barrier. 
The results of the tumor grafts from A to C3H mice demonstrate that 
immunological tolerance also can be effected across the H-2 histocompatability 
barrier by the administration of subcellular spleen fractions of the 
donor strain. A high percentage of tumor grafts were accepted m the C3H 
mouse treated with the microsomal fraction,.86% (6/7), with the 
particulate fraction, 63% (5/8). A much lower incidence of acceptance 
was accomplished with the soluble fraction; 28% (2/7) of the C3H mice 
accepted tumor grafts from A strain mice. 
Because of the impurity of these fractions, it is impossible to 
disclose the exact chemical nature of the material that induces 
immunological tolerance. It is possible that the particulate fraction 
was contaminated by microsomes, but it seems less possible that the 
microsomes were contaminated by larger cell debris. That multiple 
factors are capable of inducing tolerance is likely, and previous 
work has shown that more than one chemical species can function as 
transplantation antigens. 
The results of the experiments reported here differ from those 
93-95 
of previous studies which have shown prolonged survival of 
homografts in the rat by the administration of donor ENA. Indeed, 
96 
Traktellis et al. were able to produce permanent tolerance in 
C57B1/6 female mice to C57B1/6 male skin grafts with spleen ribosomes 
and RNA extracted from male spleens. In a preliminary study, we also 
were able to duplicate these results. Tolerance to male C57B1/-L skin 
grafts was induced in newborn female mice by the administration of 
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150-200 ug. RNA extracted from male spleen. Skin grafts were 
applied at one month of age, and 89$, (8/9) of the female mice 
grafted have retained male skin grafts for longer than eight months. 
In these experiments, destruction of the microsomal RNA did no 
reduce appreciably the ability of that fraction to induce immunological 
tolerance. And yet the administration of RNA also was able to produce 
tolerance. One may argue that both the RNAse-treated microsomes and the 
RNA act as antigens. Their excess supressed the immune response by 
antigen overloading. This argument would be consistent witn the 
apparent finding that there is not one "transplantation antigen" but 
a variety of them. It seems unlikely, however, that the small quantity 
of RNA, 200 ug., would provide sufficient antigen to paralyze the 
immune response. 
A more reasonable hypothesis is that the RNA injected into newborn 
mice enters their cells and provides information for the formation ~ of 
protein antigens that can paralyze the immune response. Since donor 
RNA is used, the proteins produced by the host would have the structure 
96 
of donor protein. The finding by Traktellis et al. that microsomal 
but not soluble RNA can induce tolerance favors this explanation. 
However, no one has shown what happens to the RNA inside the host 
animal. The high turnover of RNA may preclude its presence in the 
host animal long enough for the production of sufficient protein to 
supress the immune response. 
The findings of these experiments provide further evidence 
that tolerance is not a unique phenomenon, but is essentially the 
same as immunological paralysis and inhibition of the immune response 
by antigen overloading. 
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Tab.le I. Acceptance of C57Bl/l Male Skin Grafts by Adult C57B.l/l 
Female Mice after Multiple Injections of Subcellular Spleen Fractions. 






Uninjected control 0 2/59 3 
RNAse control 11 o/io 0 
"Tris" Buffer control 11 0/12 0 
Particulate fraction .12 5/7 71 
Microsomal fraction 12 6/8 75 
Soluble fraction 
RNAse-treated 
12 2/8 25 
microsomal fraction 
"Tris"-extracted 
11 6/11 55 
particulate fraction 11 9/11 8l 
Eibosomal fraction 
Microsomal membrane 
8 4/20 20 
fraction 8 2/8 25 
*one spleen-equivalent per injection, (avg, vrt. = 0.07 gm. / spleen.) 
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Table II. Acceptance of C57B1/.1 Male Skin Grafts by Adult C57B1/.1 
Female Mice after Multiple Injections of Subcellular Liver Fractions. 
Cell Fraction No. of No. takes/ °]o Graft 
Injections* No. grafted Acceptances 
Uninjected control 0 2/59 3 
Particulate fraction 13 19/22 86 
Microsomal fraction 13 12/16 75 
*each injection represents the amount of that fraction derived from 
approximately 0.8 gm. liver (wet weight). 
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Table III. Acceptance of BALB/C Skin Grafts by Adult C57B1/1 
Female Mice with Intact Skin Grafts from C57Bl/l Male Mice, 
Fraction with which C57B1/.1 
female mice were made tolerant 





Spleen ribosomal fraction 0/3 0 
Spleen microsomal membrance fraction 0/2 0 
Liver particulate fraction 0/l8 0 
Liver microsomal fraction 0/11 0 
Total 0/34 0 
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Table IV. Acceptance of Mammary Adenocarcinoma Grafts of Strain A Mice 
by C3H Mice after Multiple Injections of Subcellular Spleen Fractions. 






Uninjected control 0 o/io 0 
Soluble fraction 24 2/7 28 
Microsomal fraction 24 6/7 86 
Particulate fraction 24 5/8 63 
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Figure I. Photograph of control mice taken 70 days after 
grafting with male skin. The skin grafts are shrunken 
and are represented only by a small piece of scar tissue. 
There is no hair growth. 
■ 
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Figure II. Photograph of C57Bl/l female mice made 
tolerant to male skin grafts with the spleen microsome 
fraction. The grafts maintain their original size, and 
a luxuriant growth of hair can he seen. 
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Figure III. Photograph of C57B1/1 female mice made 
tolerant to C57B1/1 male skin hy previous treatment 
with the ENAse-treated microsomal fraction. Although 
all of the host’s hair has not yet regrown, a good 
growth of hair on the grafts can he seen. The hair on 
the graft is longer and coarser than the host’s hair 
and has lost its pigmentation. This picture was taken 
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